Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1625 of 3546 entries
View as:

A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00501930 Org: User:
Start: 04/30/07 End: - Due: -

A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02275052 Org: User:
Start: 01/23/15 End: 06/02/16 Due: 06/02/17

Study to Assess the Pharmacokinetics of GSK1278863 in Subjects With End Stage Renal Disease Undergoing Peritoneal Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02243306 Org: User:
Start: 10/24/14 End: 05/10/17 Due: 05/10/18

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

Phase: N/A Priority: Normal
NCT ID: NCT00829010 Org: User:
Start: 02/17/09 End: 06/27/12 Due: 06/27/13

Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese Males

Phase: N/A Priority: Normal
NCT ID: NCT01428479 Org: User:
Start: 01/07/11 End: 04/04/11 Due: 04/04/12

FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

Phase: N/A Priority: Normal
NCT ID: NCT03046069 Org: User:
Start: 02/20/17 End: 02/23/18 Due: 02/23/19

Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults

Phase: N/A Priority: Normal
NCT ID: NCT02377401 Org: User:
Start: 04/28/15 End: 06/19/15 Due: 06/19/16

Evaluation of Efficacy of Experimental Gel to Foam Dentifrices in Dental Erosion

Phase: N/A Priority: Normal
NCT ID: NCT01657903 Org: User:
Start: 11/30/11 End: 02/29/12 Due: 02/28/13

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00517673 Org: User:
Start: 07/31/07 End: 09/30/08 Due: 09/30/09

Effect of GSK704838 In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00539825 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00517634 Org: User:
Start: 08/31/07 End: 07/31/08 Due: 07/31/09

Pharmacokinetic Study Investigating the Extent of Paracetamol Absorption From a New Formulation of Paracetamol Compared With Panadol® Extend

Phase: N/A Priority: Normal
NCT ID: NCT01540721 Org: User:
Start: 12/31/09 End: 12/31/09 Due: 12/31/10

A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential

Phase: N/A Priority: Normal
NCT ID: NCT02706535 Org: User:
Start: 05/05/16 End: 01/06/17 Due: 01/06/18

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01059617 Org: User:
Start: 02/09/10 End: 10/21/11 Due: 10/21/12

AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00359112 Org: User:
Start: 02/29/04 End: - Due: -

Pertussis Infection in Adolescents and Adults With Prolonged Cough

Phase: N/A Priority: Normal
NCT ID: NCT01597687 Org: User:
Start: 06/20/12 End: 05/02/13 Due: 05/02/14

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

Phase: N/A Priority: Normal
NCT ID: NCT02112890 Org: User:
Start: 12/10/14 End: 05/02/16 Due: 05/02/17

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT00309647 Org: User:
Start: 03/29/06 End: 11/16/06 Due: 11/16/07

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT01003418 Org: User:
Start: 11/17/09 End: 11/25/10 Due: 11/25/11

A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.

Phase: N/A Priority: Normal
NCT ID: NCT00432380 Org: User:
Start: 03/09/07 End: 09/04/07 Due: 09/04/08

CR9112792, a Follow-up of Study CR9108963

Phase: N/A Priority: Normal
NCT ID: NCT00891553 Org: User:
Start: 03/31/09 End: 06/30/09 Due: 06/30/10

Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product

Phase: N/A Priority: Normal
NCT ID: NCT00291382 Org: User:
Start: 11/30/05 End: 07/31/07 Due: 07/31/08

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT00345579 Org: User:
Start: 09/30/06 End: 03/31/08 Due: 03/31/09

Sun Protection Factor (SPF) Determination of Two Sunscreen-Containing Lip Balms

Phase: N/A Priority: Normal
NCT ID: NCT04749459 Org: User:
Start: 03/03/21 End: 03/31/21 Due: 03/31/22

Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT01974895 Org: User:
Start: 10/23/13 End: 07/03/14 Due: 07/03/15